pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
590
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
glenzocimab
Acute Ischemic Stroke
Platelet glycoprotein VI
Acticor Biotech SAS
0
catalysts
Phase 3
glufosfamide
glufosfamide [INN]
Metastatic Adenocarcinoma of The Pancreas
Eleison Pharmaceuticals Inc
0
catalysts
Phase 3
glyburide
Cirara (glyburide)
Diabetes
Sulfonylurea receptor 1, Kir6.2
← prev
page 12 of 20
next →
131
Pain
89
Neurology
1
$ETON
Eton Pharmaceuticals, Inc.
0
catalysts
Phase 3
gotistobart
Non-Small Cell Lung Cancer
OncoC4 Inc
0
catalysts
Phase 3
gusacitinib hydrochloride
Hand Dermatitis
$SNY
Sanofi
0
catalysts
Phase 3
hydrocortisone MR
Chronocort (hydrocortisone [INN])
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)
$NBIX
NEUROCRINE BIOSCIENCES INC
0
catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGX
SOLIGENIX, INC.
0
catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVS
NOVARTIS AG
0
catalysts
Phase 3
ibramvibart
ibramvibart [INN]
Coronavirus Disease 2019 (COVID-19)
$IVVD
Invivyd, Inc.
0
catalysts
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
0
catalysts
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOV
MEDICINOVA INC
0
catalysts
Phase 3
ibutamoren mesylate
Oratrope (ibutamoren mesylate)
Growth Hormone Deficiency
Growth hormone secretagogue receptor type 1
Lumos Pharma Inc
0
catalysts
Phase 3
ibuzatrelvir
Coronavirus Disease 2019 (COVID-19)
$PFE
PFIZER INC
0
catalysts
Phase 3
iltamiocel
Stress Urinary Incontinence
Cook MyoSite Inc
0
catalysts
Phase 3
imeroprubart
Rheumatoid Arthritis
$IMVT
Immunovant, Inc.
0
catalysts
Phase 3
inaxaplin
Focal Segmental Glomerulosclerosis (FSGS)
$VERX
Vertex, Inc.
0
catalysts
Phase 3
influenza (quadrivalent) vaccine
Influenzavirus A Infections
$PFE
PFIZER INC
0
catalysts
Phase 3
influenza (trivalent) vaccine
Seasonal Influenza
$NVAX
NOVAVAX INC
0
catalysts
Phase 3
insulin human (recombinant)
insulin human
Malabsorption Syndrome
Insulin receptor
Elgan Pharma Ltd
0
catalysts
Phase 3
iodine i 131 apamistamab
Iomab-B (iodine i 131 apamistamab)
Refractory Acute Myeloid Leukemia
$ATNM
Actinium Pharmaceuticals, Inc.
0
catalysts
Phase 3
ipilimumab + nivolumab
Opdivo + Yervoy (ipilimumab + nivolumab)
Gastric Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 3
ipsoprubart
ipsoprubart [INN]
Hemophagocytic Lymphohistiocytosis
Electra Therapeutics Inc
0
catalysts
Phase 3
iron sucrose + stannic protoporfin
Acute Renal Failure (ARF) (Acute Kidney Injury)
Renibus Therapeutics Inc
0
catalysts
Phase 3
isoflurane
Isoflurane (isoflurane)
Sedation
Potassium channel subfamily K member 2
Potassium channel subfamily K member 9
Sedana Medical AB
0
catalysts
Phase 3
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
Interleukin-33
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
ivarmacitinib sulfate
Ulcerative Colitis
Reistone Biopharma Co Ltd
0
catalysts
Phase 3
ivospemin hydrochloride
Pancreatic Ductal Adenocarcinoma
Panbela Therapeutics Inc
0
catalysts
Phase 3
ixoberogene soroparvovec
Wet (Neovascular / Exudative) Macular Degeneration
Adverum Biotechnologies Inc
0
catalysts
Phase 3
izalontamab brengitecan
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 3
larsucosterol sodium
Alcoholic Hepatitis
$BHC
Bausch Health Companies Inc.
0
catalysts
